Connor, Clark & Lunn Investment Management (CC&L)
FDMT icon

Connor, Clark & Lunn Investment Management (CC&L)’s 4D Molecular Therapeutics FDMT Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
2024
Q4 		$364K Buy
2024
Q3 		$295K Buy
2023
Q3 		– Sell
2023
Q2 		$394K Sell
2023
Q1 		$839K Buy
2022
Q4 		$1.07M Buy